batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Triple meeting 2024 – Cogent diversifies 23 October 2024 Merck and Daiichi look beyond small cell with ifinatamab 22 October 2024 Editas turns away from ex vivo 22 October 2024 Another hold for BioNTech 21 October 2024 On a wing and a prayer, Bristol takes GM1 pivotal 21 October 2024 New Roche/Poseida project isn’t P-BCMACD19-ALLO1 18 October 2024 LaNova enters oncology’s hottest licensing territory 18 October 2024 Bladder no-go, but Trodelvy has bigger problems 18 October 2024 Load More